Skip to main content

Seaport Therapeutics, Inc.

corporate_fare Company Profile

Seaport Therapeutics, Inc.

SPTX·NASDAQ·Life Sciences·CIK 0002042347

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on developing new neuropsychiatric medicines. The company creates therapeutic candidates for conditions like depression and anxiety disorders. Its proprietary Glyph technology platform is central to its development efforts. This platform is designed to improve oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations, hepatotoxicity, and other side effects. All therapeutic candidates currently in development utilize this Glyph platform, with research and development activities specifically targeting neuropsychiatric medicines. Seaport Therapeutics, Inc. serves clinicians and key opinion leaders within the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is headquartered in Boston, Massachusetts.

Seaport Therapeutics, Inc. (NASDAQ:SPTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for SPTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-09, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for SPTX spans 10-Q, 8-K, SCHEDULE 13D, 4.

Recent high-impact activity:

  • GlyphAgo Phase 1 PK Shows 6.8x Bioavailability, 10x Lower Variability
  • Seaport Doses First Patient in Phase 2a Trial of GlyphAgo for Anxiety
  • Seaport's GlyphAllo Shows No Driving Impairment in Phase 1, Boosting MDD Program
  • Seaport Therapeutics Q2 2026: Cash Runway Extended to 2029, Pipeline Advances
  • Seaport Therapeutics Q2 2026: $427M Cash, Pipeline Progress, and $260M Upsized IPO

Short Interest & Short Volume

17.42 days to cover

FINRA reported short interest of 3,733,388 shares in SPTX as of the October 30, 2026 settlement, a 0.4% increase from the prior period — about 17.4 days to cover at its recent average daily volume. On November 20, 2026, 73.8% of SPTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,733,388 shares as of October 30, 2026
Change vs prior period▲ 0.4%
Days to cover17.42 at avg daily volume of 214,337
Daily short volume (FINRA facilities)73.8% of 116,016 shares on November 20, 2026
5-day average short volume82.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$18.32
52-week range · as of 2026-08-03 $14.85 – $22.98
Market cap
$966.23M
Volume
284.3K (1.0× avg)
3-mo avg 274.1K
Live data · 2026-11-22 12:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SPTX - Latest Insights

SPTX
Oct 09, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $18.18
Real-time Price: $18.32 info
Change: +$0.140 (+0.77%) info
Market Cap: $966.226M info
SPTX
Oct 07, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $17.37
Real-time Price: $18.32 info
Change: +$0.950 (+5%) info
Market Cap: $966.226M info
SPTX
Sep 09, 2026, 1:13 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $22.99
Real-time Price: $18.32 info
Change: -$4.66 (-20%) info
Market Cap: $966.226M info
SPTX
Aug 03, 2026, 7:11 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $20.46
Real-time Price: $18.32 info
Change: -$2.14 (-10%) info
Market Cap: $966.226M info
SPTX
Aug 03, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.46
Real-time Price: $18.32 info
Change: -$2.14 (-10%) info
Market Cap: $966.226M info
SPTX
Aug 03, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $20.46
Real-time Price: $18.32 info
Change: -$2.14 (-10%) info
Market Cap: $966.226M info
SPTX
Jun 08, 2026, 7:15 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $16.44
Real-time Price: $18.32 info
Change: +$1.88 (+11%) info
Market Cap: $966.226M info
SPTX
Jun 08, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $16.44
Real-time Price: $18.32 info
Change: +$1.88 (+11%) info
Market Cap: $966.226M info
SPTX
Jun 08, 2026, 7:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $16.44
Real-time Price: $18.32 info
Change: +$1.88 (+11%) info
Market Cap: $966.226M info
SPTX
May 11, 2026, 7:54 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $15.25
Real-time Price: $18.32 info
Change: +$3.07 (+20%) info
Market Cap: $966.226M info
SPTX
May 06, 2026, 4:26 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.00
Real-time Price: $18.32 info
Change: +$2.32 (+15%) info
Market Cap: $966.226M info
SPTX
May 04, 2026, 6:02 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $16.70
Real-time Price: $18.32 info
Change: +$1.62 (+10%) info
Market Cap: $966.226M info
SPTX
May 01, 2026, 5:31 PM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $19.78
Real-time Price: $18.32 info
Change: -$1.46 (-7%) info
Market Cap: $966.226M info
SPTX
Apr 30, 2026, 9:58 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: N/A
Real-time Price: $18.32 info
Change: N/A info
Market Cap: $966.226M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets